A combination of IFNγ and dupilumab, i.e., IL-4/IL-3 receptor inhibitor, can promote remission in refractory disseminated coccidioidomycosis where inborn errors of immunity were detected in the child (195). The gene discussed is IFNG; the disease is coccidioidomycosis.